Minjung Kim

发表

A Hypoxia- and α-Fetoprotein–Dependent Oncolytic Adenovirus Exhibits Specific Killing of Hepatocellular Carcinomas

C. Yun, Pyung-Hwan Kim, O. Kwon, 2010, Clinical Cancer Research.

Cancer Therapy: Preclinical A Hypoxia- and a -Fetoprotein – Dependent Oncolytic Adenovirus Exhibits Specific Killing of Hepatocellular Carcinomas

C. Yun, Pyung-Hwan Kim, O. Kwon, 2010 .

Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration.

S. W. Kim, C. Yun, Pyung-Hwan Kim, 2011, Biomaterials.

Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma.

W. Koom, J. Seong, C. Yun, 2012, Journal of radiation research.

149. Coxsackie and Adenovirus Receptor Binding Ablation Reduces Adenovirus Liver Tropism and Toxicity

A. Yoon, C. Yun, J. Yoo, 2006 .

Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity.

Joo‐Hang Kim, G. Kim, A. Yoon, 2005, Human gene therapy.

Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis

C. Yun, Sang-Bum Hong, Taewon Lee, 2020, Frontiers in Immunology.

Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy.

Jungho Kim, C. Yun, I. Choi, 2012, Human gene therapy.

Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions

A. Yoon, Jinwoo Hong, C. Yun, 2018, Scientific Reports.

KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A.

K. Nephew, D. Koh, B. Jeon, 2012, Cancer research.

Transcription of p21WAF1/CDKN1A KR-POK Interacts with p53 and Represses Its Ability to Activate

K. Nephew, D. Koh, B. Jeon, 2012 .

Molecular and Cellular Pathobiology KR-POK Interacts with p 53 and Represses Its Ability to Activate Transcription of p 21 WAF 1 / CDKN 1 A

K. Nephew, D. Koh, B. Jeon, 2012 .

B cell–intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice

M. Shlomchik, S. Bastacky, J. Tilstra, 2023, JCI insight.

Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma

Y. N. Park, M-O Lee, J. Seong, 2016, Oncogene.